• 1
    Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007;7:61021.
  • 2
    Manicassamy S, Pulendran B. Dendritic cell control of tolerogenic responses. Immunol Rev 2011;241:20627.
  • 3
    Fu B, He X, Yu S et al. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4 +  CD25 +  T regulatory cells that promotes skin allograft survival in mice. Cell Immunol 2010;261:6976.
  • 4
    Gilliet M, Liu YJ. Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Hum Immunol 2002;63:114955.
  • 5
    Lan YY, Wang Z, Raimondi G et al. “Alternatively activated” dendritic cells preferentially secrete IL-10, expand Foxp3+ CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 2006;177:586877.
  • 6
    Toubai T, Malter C, Tawara I et al. Immunization with host-type CD8α+ dendritic cells reduces experimental acute GVHD in an IL-10–dependent manner. Blood 2010;115:72435.
  • 7
    Zhang X, Li M, Lian D, Zheng X, Zhang ZX, Ichim TE. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin Immunol 2008;127:31321.
  • 8
    Homann D, Jahreis A, Wolfe T et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 2002;16:40315.
  • 9
    Liang X, Lu L, Chen Z et al. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation 2003;76:721.
  • 10
    Lagaraine C, Lebranchu Y. Effects of immunosuppressive drugs on dendritic cells and tolerance induction. Transplantation 2003;75:37S.
  • 11
    Matyszak MK, Citterio S, Rescigno M, Ricciardi-Castagnoli P. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 2000;30:123342.
  • 12
    Chen T, Guo J, Yang M et al. Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 2004;103:41321.
  • 13
    Turnquist HR, Raimondi G, Zahorchak AF, Fischer RT, Wang Z, Thomson AW. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4 +  T cells, but enrich for antigen-specific Foxp3 +  T regulatory cells and promote organ transplant tolerance. J Immunol 2007;178:701831.
  • 14
    Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1α, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001;167:194553.
  • 15
    Torres-Aguilar H, Aguilar-Ruiz SR, González-Pérez G et al. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol 2010;184:176575.
  • 16
    Zhou F, Lauretti E, di Meco A et al. Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity. Immunobiology 2013;218:106976.
  • 17
    Sato K, Yamashita N, Baba M, Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 2003;18:36779.
  • 18
    Fujita S, Seino K, Sato K et al. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 2006;107:3656.
  • 19
    Fujita S, Sato Y, Sato K et al. Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+ CD25+ Foxp3+ regulatory T cells. Blood 2007;110:3793803.
  • 20
    Pfaffl MW. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res 2001;29:e45.
  • 21
    Yang J, Gao L, Liu Y et al. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation. Transfusion 2010;50:40717.
  • 22
    Cooke KR, Kobzik L, Martin T et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996;88:32309.
  • 23
    Kaplan DH, Anderson BE, McNiff JM, Jain D, Shlomchik MJ, Shlomchik WD. Target antigens determine graft-versus-host disease phenotype. J Immunol 2004;173:5467.
  • 24
    Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005;22:32941.
  • 25
    Dickinson A, Holler E. Polymorphisms of cytokine and innate immunity genes and GVHD. Best Pract Res Clin Haematol 2008;21:14964.
  • 26
    Kitade H, Kawai M, Rutgeerts O et al. Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusion. J Immunol 2005;175:4963.
  • 27
    Chan WF, Razavy H, Anderson CC. Differential susceptibility of allogeneic targets to indirect CD4 immunity generates split tolerance. J Immunol 2008;181:460312.
  • 28
    Smyth LA, Ratnasothy K, Moreau A et al. Tolerogenic donor-derived dendritic cells risk sensitization in vivo owing to processing and presentation by recipient APCs. J Immunol 2013;190:484860.